IL10 (Interleukin 10)

News alerts, weekly reports and conference planners

Entrez ID:

IL10 elevation	Peripheral T-cell Lymphoma	IL10 elevation	Peripheral T-cell Lymphoma	CHOP Resistant: C3 – Early Trials CHOP Resistant : C3	CHOP Resistant: C3 – Early Trials CHOP Resistant : C3
IL10 overexpression	Breast Cancer	IL10 overexpression	Breast Cancer	palbociclib Resistant: C3 – Early Trials palbociclib Resistant : C3	palbociclib Resistant: C3 – Early Trials palbociclib Resistant : C3
IL10-L	Melanoma	IL10-L	Melanoma	nivolumab + ipilimumab Sensitive: C3 – Early Trials nivolumab + ipilimumab Sensitive : C3	nivolumab + ipilimumab Sensitive: C3 – Early Trials nivolumab + ipilimumab Sensitive : C3
IL10-L	Cutaneous T-cell Lymphoma	IL10-L	Cutaneous T-cell Lymphoma	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3
IL10-L	Peripheral T-cell Lymphoma	IL10-L	Peripheral T-cell Lymphoma	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3

Associations(5)